FDA drafts guidance on genome editing, CAR T cell therapies
Regulatory NewsMary Ellen Schneider
BiologicsBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaProduct LifecycleRegulatory NewsMary Ellen SchneiderBiologicsBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsNorth AmericaProduct Lifecycle